XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statements of Stockholders Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Beginning Balance at Dec. 31, 2022 $ 99,885   $ 154,891 $ (55,006)
Beginning Balance (in shares) at Dec. 31, 2022   28,179,423    
Stock-based compensation 4,137   4,137  
Issuance of common stock upon exercise of stock options In Shares   51,774    
Issuance of common stock upon exercise of stock options 76   76  
Issuance of common stock under employee stock purchase plan (In Share)   148,102    
Issuance of common stock under employee stock purchase plan 252   252  
Vesting of restricted stock units, Shares   28,071    
Equity financing, net of issuance costs (in shares)   12,386,478    
Equity financing, net of issuance costs 22,466   22,466  
Net Income (Loss) (36,780)     (36,780)
Ending Balance at Dec. 31, 2023 $ 90,036   181,822 (91,786)
Ending Balance (in shares) at Dec. 31, 2023 40,793,848 40,793,848    
Stock-based compensation $ 3,666   3,666  
Issuance of common stock warrants 132   132  
Issuance of common stock upon exercise of warrant, Shares   65,036    
Issuance of common stock upon exercise of warrant 0   0  
Issuance of common stock upon exercise of stock options In Shares   8,865    
Issuance of common stock upon exercise of stock options 29   29  
Issuance of common stock under employee stock purchase plan (In Share)   88,926    
Issuance of common stock under employee stock purchase plan 135   135  
Vesting of restricted stock units, Shares   67,169    
Equity financing, net of issuance costs (in shares)   12,385,883    
Equity financing, net of issuance costs 15,141 $ 1 15,140  
Net Income (Loss) (26,745)     (26,745)
Ending Balance at Dec. 31, 2024 $ 82,394 $ 1 $ 200,924 $ (118,531)
Ending Balance (in shares) at Dec. 31, 2024 53,409,727 53,409,727